Are you Dr. Sternberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1190 5th Ave
# Mount
New York, NY 10029Phone+1 212-241-6756Fax+1 212-423-0522
Summary
- Dr. David Sternberg, MD is an oncologist in New York, New York. He is currently licensed to practice medicine in New York. He is affiliated with The Mount Sinai Hospital and is an Adjunct Assistant Professor Med at Icahn School of Medicine at Mount Sinai.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1995
Weill Cornell MedicineClass of 1993
Certifications & Licensure
NY State Medical License 2004 - 2025
Publications & Presentations
PubMed
- 302 citationsEfficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C. Kluin-Nelemans, Tracy I. George, Cem Akin, Karl Sotlar
The New England Journal of Medicine. 2016-06-29 - 65 citationsA Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung...Fred R. Hirsch, Fairooz F. Kabbinavar, Tim Eisen, Renato G. Martins, Fredrick M. Schnell
Journal of Clinical Oncology. 2011-09-10 - 14 citationsTHOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover.Andrew Pierce, Louise Carney, Hajja G. Hamza, John R. Griffiths, Liqun Zhang
British Journal of Haematology. 2008-06-01
Grant Support
- Signal Transduction By Tel/Tyrosine Kinase FusionsNational Cancer Institute2003
- Signal Transduction By Tel/Tyrosine Kinase FusionsNational Cancer Institute1999–2003
